Safety and Immunogenicity Study of a Bivalent Vaccine for Combined Prophylaxis of COVID-19 and Influenza in Non-Human Primates
The candidate bivalent vaccine was safe and immunogenic for non-human primates and warrants its further evaluation in clinical trials.
Authors
- Ekaterina Bazhenova (ORCID: https://orcid.org/0000-0003-3280-556X)
- Д. Д. Карал-оглы (ORCID: https://orcid.org/0000-0003-3606-1668)
- Polina Prokopenko (ORCID: https://orcid.org/0000-0002-7247-979X)
- Alexandra Rak (ORCID: https://orcid.org/0000-0001-5552-9874)
- Ekaterina Stepanova (ORCID: https://orcid.org/0000-0002-8670-8645)
- К. В. Сивак (ORCID: https://orcid.org/0000-0003-4064-5033)
- Larisa Rudenko (ORCID: https://orcid.org/0000-0002-0107-9959)
- Tatiana Kotomina (ORCID: https://orcid.org/0000-0001-9999-089X)
- Svetlana Donina (ORCID: https://orcid.org/0000-0002-6502-8341)
- Anna Chistiakova (ORCID: https://orcid.org/0000-0001-9541-5636)
- Victoria Matyushenko (ORCID: https://orcid.org/0000-0002-4698-6085)
- Igor Kudryavtsev (ORCID: https://orcid.org/0000-0002-0005-3095)
- Vlada Novitskaya
- Arina Kostromitina
- Daria Mezhenskaya
- Irina Isakova-Sivak
Institutions
- Federal State Budgetary Scientific Institution Research Institute of Medical Primatology (RU)
- Institute of Experimental Medicine (RU)
- Research Institute of Influenza (RU)
Publication Details
- Journal
- Vaccines
- Published
- 2024-09-26
- DOI
- https://doi.org/10.3390/vaccines12101099
- Citations
- 3
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 1.17
Funders
- Russian Science Foundation